Human Papilloma Virus - HPV
How dangerous is HPV? The medical facts may surprise you!
www.health-science-report.comAdvertise here

Best Fundraiser Ever!
No up front costs. No minimums.
75% profit. No delays. Start today.
For groups, teams, individuals, schools.

www.NorthPoleFundraising.com

HPV Virus Research - Pregnancy


Sex Transm Infect. 2005 Jun;81(3):242-7.

Bacterial vaginosis in relation to menstrual cycle, menstrual protection method, and sexual intercourse in rural Gambian women.

Morison L, Ekpo G, West B, Demba E, Mayaud P, Coleman R, Bailey R, Walraven G. MRC Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.

OBJECTIVE: To examine the occurrence of bacterial vaginosis (BV) over the menstrual cycle and in relation to menstrual protection materials and sexual intercourse in a rural African setting. METHODS: Married, regularly menstruating female volunteers were asked to collect self administered swabs on alternate days through four menstrual cycles. BV was assessed using Nugent scores. Menstruation and reported sexual intercourse data were recorded contemporaneously. A crossover design comparing traditional and modern menstrual protection methods was incorporated. Multivariate logistic regression was used to examine associations with BV. RESULTS: 30 women completed four menstrual cycles in the study. Completeness and validity of data from the self administered swabs was high. Greater frequencies of BV were found for all women in the second week of the menstrual cycle relative to days 14+, and markedly higher frequencies of BV were found in the first week in women with infrequent BV. BV was (non-significantly) more frequent when modern pads were used compared with traditional cloths. No association was found between BV and intercourse reported in the previous 4 days; or between the frequency of reported intercourse in one menstrual cycle and BV in either the same menstrual cycle or the next. CONCLUSIONS: Similar transient fluctuations over the menstrual cycle were found to those in industrialised countries. We found no evidence that sexual intercourse was associated with increased frequency of BV. Our data do not support hypotheses that menstrual hygiene materials might explain the high prevalences of BV found in sub-Saharan Africa compared to industrialised countries.


Eur J Obstet Gynecol Reprod Biol. 2005 May 11; [Epub ahead of print]

Detection of interleukin 6 mRNA by RT-PCR in vaginal secretions: association with preterm delivery and neonatal infection in women with preterm labour and intact membranes.

Goffinet F, Kayem G, Maillard F, Trebeden H, Cabrol D, Weill B, Batteux F. Department of Obstetrics and Gynecology, Maternity Port-Royal, Cochin-Saint Vincent-de-Paul Hospital, University Paris V, 123 Bd de Port-Royal, 75014 Paris, France; Epidemiological Research Unit on Perinatal and Women's Health, INSERM U 149, 123 Bd de Port-Royal, 75014 Paris, France.

OBJECTIVE:: To find a biological marker associated with preterm delivery or neonatal infection in pregnant women with preterm labour and intact membranes. STUDY DESIGN:: Cervical secretions were collected from 286 women hospitalized for preterm labour with intact membranes at 24-34 weeks' gestation. The outcomes studied were delivery before 33 and 35 weeks' gestation, chorioamnionitis, and neonatal infection, and their association with the presence of IL-6 mRNA in cervical secretions as detected by RT-PCR. The other infectious markers tested were: bacterial vaginosis and fetal fibronectin in cervical secretions; serum CRP and white blood cell count. RESULTS:: The vaginal secretions of 13 of 286 women (4.7%) contained IL-6 mRNA. The only other marker tested significantly associated with IL-6 mRNA+ was the presence of streptococcus in vaginal secretions (30.8% versus 9.4% in the IL-6+ and-groups, p=0.03). Although the difference did not reach statistical significance (p<0.06 and 0.08, respectively), in women with IL-6 mRNA in cervical secretions we observed a tendency to give birth before 33 and 35 weeks more often than the population as a whole. This group was at higher risk of neonatal infection (38.5% versus 15.1%; p=0.04). After adjustment for infectious risk factors, IL-6 remained significantly associated with neonatal infection (OR=4.6, 95% CI [1.1-18.9]). The sensitivity of IL-6 mRNA for neonatal infection was 11.1%. The specificity was 96.7%. CONCLUSION:: The detection of IL-6 mRNA by RT-PCR in vaginal secretions allows identification of a small group of women at high risk of neonatal infection, independently of other markers of infection.


J Indian Med Assoc. 2004 Oct;102(10):548-50, 553.

Bacterial vaginosis and vaginal anaerobes in preterm labour.

Goyal R, Sharma P, Kaur I, Aggarwal N, Talwar V. Department of Microbiology, University College of Medical Sciences, Delhi 110095.

Maternal genital infections, particularly bacterial vaginosis has been implicated as a cause for preterm labour and adverse pregnancy outcomes. This prospective study aimed to study the association of bacterial vaginosis with preterm labour. The prevalence of bacterial vaginosis was studied in 60 women in preterm labour who had no recognisable cause for prematurity and in 60 term labour controls. Demographic factors, pregnancy outcome and reproductive history were also studied. Vaginal specimens for Gram-stain and culture were collected from posterior vaginal fomix and bacterial vaginosis was defined by evaluation of Gram-stained smear by Spiegel criteria. Bacterial vaginosis was diagnosed in 31.6% of women in preterm labour and in 15% of term labour controls ( p<0.05). In preterm labour group, preterm delivery occurred in 48 women (80%) out of which 18 women had bacterial vaginosis and term delivery occurred in only one woman with the condition. Anaerobes were significantly associated with bacterial vaginosis ( p<0.01) and were more common in women with preterm labour ( b>0.05). The results indicates that bacterial vaginosis has a significant association with preterm labour and adverse pregnancy outcome.


Acta Obstet Gynecol Scand. 2005 Jun;84(6):516-25.

Biomarkers for the prediction of preterm delivery.

Vogel I, Thorsen P, Curry A, Sandager P, Uldbjerg N. Department of Epidemiology and Social Medicine, NANEA, University of Aarhus, Aarhus, Denmark.

This structured review discusses the current literature on selected biomarkers and their ability to predict preterm delivery (PTD). Among symptomatic women, the likelihood ratio (LR+) for the prediction of PTD was found to be greater than 10 using amniotic fluid (AF) interleukin-6 (IL-6), AF Ureaplasma urealyticum, as well as a multi-marker consisting of cervical IL-6, cervical IL-8, and cervical length (CL). The LR+ was found to be between 5 and 10 for serum C-reactive protein (CRP). An LR+ between 2.5 and 5 was recorded for serum corticotropin-releasing hormone (CRH), cervical fetal fibronectin (fFN), cervical IL-6, serum relaxin, and a multi-marker consisting of fFN and CL. CL and bacterial vaginosis (BV) both predicted PTD in women with preterm labor with an LR+ of less than 2.5. In asymptomatic women, AF U. urealyticum and a multimarker consisting of five individual markers [fFN, CL, serum alpha-fetoprotein (AFP), serum alkaline phosphatase, and serum granulocyte colony-stimulating factor (G-CSF)] predicted PTD with an LR+ greater than 10. The LR+ was between 5 and 10 for serum relaxin and CL. LRs+ recorded for serum alkaline phosphatase, salivary estriol, serum CRH, serum G-CSF, cervical IL-6, AF IL-6, cervical fFN, AFP, and Chlamydia all ranged between 2.5 and 5. Finally, an LR+ below 2.5 has been documented for serum ferritin, serum CRP, BV, and cervical ferritin.


Arch Pediatr. 2005 May;12(5):514-9.

Genital bacterial carriage during the last trimester of pregnancy and early-onset neonatal sepsis.

HPV Virus Research - Article in French

Balaka B, Agbere A, Dagnra A, Baeta S, Kessie K, Assimadi K. Service de pediatrie, centre hospitalier universitaire de Lome, Togo.

Bacterial infections remain a major cause of morbidity and mortality in newborn infants. Objective. - To determine the bacterial ecology and pathological status of the genital organs during the last trimester of pregnancy and the germs of the following early-onset neonatal sepsis, in order to evaluate the risk of materno-foetal infections and to find out a drug prophylaxis. Method. -Vaginal and endocervical samples, usually taken during the first trimester of pregnancy were delayed and taken during the last trimester of pregnancy. A macroscopic examination described the aspect of the vagina, the cervix uteri, leukorrhea and of possible inflammatory lesions or ulcerations. A microscopic examination searched for parasites, epithelial cells, clue cells and leukocytes. The appropriate bacteriological cultures were performed after reading the Gram stain and scoring the vaginal flora. The clinical and cytobacteriological aspects were used to identify the bacterial ecology and the pathological genital states. An exploration was carried out in every newborn suspected of infection. Results. - Genital samples were collected from 306 pregnant women. Among them, 118 were at 29-32 weeks of gestation, 104 at 33-36, and 84 at 37-40. The most frequent germs were C. albicans (33,5%), Enterbacteriaceae (20.3%) including E. coli (10.9%), S. aureus (15.4%), Gardnerella (13.6%), and Trichomonas (10.6%), in monomicrobian (79.2%) and polymicrobian carriage (20.8%). Lower genital tract pathological states such as vaginitis (29.4%), bacterial vaginosis (21.5%) or endocervicitis (10.4%), asymptomatic bacterial carriage (23.5%) and normal genital flora (15%) were identified. These pregnancies led to 334 live births with 27 cases of early-onset neonatal sepsis to which endocervicitis (25%) and vaginosis (19,7%) were most often linked. Conclusion. - Genital samples at the last trimester of pregnancy could evaluate the risk of maternofoetal infections and allow to adapt a drug prophylaxis of Enterobacteriaceae, the most frequent germ of neonatal infections, as it has been done for Streptococcus agalactiae. But larger studies are required to evaluate the risk of maternofoetal infections and to state the drug prophylaxis.


Am Fam Physician. 2005 Apr 15;71(8):1555-60.

Evidence-based prenatal care: part II. Third-trimester care and prevention of infectious diseases.

Kirkham C, Harris S, Grzybowski S. University of British Columbia Faculty of Medicine, Vancouver, British Columbia.

All pregnant women should be offered screening for asymptomatic bacteriuria, syphilis, rubella, and hepatitis B and human immunodeficiency virus infection early in pregnancy. Women at increased risk should be tested for hepatitis C infection, gonorrhea, and chlamydia. All women should be questioned about their history of chickenpox and genital or orolabial herpes. Routine screening for bacterial vaginosis is not recommended. Influenza vaccination is recommended in women who will be in their second or third trimester of pregnancy during flu season. Women should be offered vaginorectal culture screening for group B streptococcal infection at 35 to 37 weeks' gestation. Colonized women and women with a history of group B streptococcal bacteriuria should be offered intrapartum intravenous antibiotics. Screening for gestational diabetes remains controversial. Women should be offered labor induction after 41 weeks' gestation.

    Publication Types:
  • Review
  • Review, Tutorial

HPV Virus Research - Vaginosis and Pregnancy Links

Bacterial Vaginosis in Pregnancy - Everything that future mothers should know about bacterial vaginosis.

Diseases in Pregnancy - Read about major risk factors for future mothers.

Screening for Bacterial Vaginosis - Recommendations and information on bacterial vaginosis in pregnancy.

Picture of HPV Virus, Sign of HPV, Oral HPV, Natural Cure for HPV, Condition HPV More SymptomHPV Photo Symptom, Oral HPV, High Risk HPV Type, Colposcopy HPV, HPV166Cervical Cancer Human Papilloma Virus, Human Papillomavirus Picture, Cervical Cancer and Human Papilloma Virus, Genital Wart Photo, Natural Cure for Genital WartLow Grade Cervical Dysplasia, Cervical Dysplasia Natural Treatment, Cervix Cancer, ASCUS, Irregular Pap Smear

Additional site navigation: Anal HPV, HPV Picture Symptom Wart, HPV Vaccine, Vaginal HPV Infection, Picture of HPV Infection, HPV, HPV Information, Pictures of HPV, Picture of HPV Virus, Sign of HPV
Popular topics: Picture of HPV Virus, HPV Cure, HPV Man, Sign of HPV, HPV and Pregnancy, HPV Virus, Vaginal HPV Infection, HPV Treatment, HPV Test, HPV Virus Symptom

Treating
Pregnancy
Risks

Copyright © 2002-2009 www.hpv-virus-research.org
All Rights Reserved.